https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-16 / 2019 May;19(1):460
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-16 / 2019 May;19(1):4602019-05-16 00:00:002020-10-05 10:19:52Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-11 / Exp Ther Med 2018 Dec;16(6):5123-5129
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-11 / Exp Ther Med 2018 Dec;16(6):5123-51292018-10-11 00:00:002018-10-11 00:00:00Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-29 / J Immunother Cancer 2018 Sep;6(1):96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-29 / J Immunother Cancer 2018 Sep;6(1):962018-09-29 00:00:002019-02-15 08:39:11A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-13 / 2018 11;103:98-107
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-13 / 2018 11;103:98-1072018-09-13 00:00:002020-10-05 10:21:06Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-05-01 / Ann. Oncol. 2018 May;29(5):1312-1319
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-05-01 / Ann. Oncol. 2018 May;29(5):1312-13192018-05-01 00:00:002019-02-15 08:39:10Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-01-11 / J. Cell. Biochem. 2018 04;119(4):3763-3774
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-01-11 / J. Cell. Biochem. 2018 04;119(4):3763-37742018-01-11 00:00:002019-02-15 08:39:30Hyperthermia enhances radiosensitivity of colorectal cancer cells through ROS inducing autophagic cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-01-01 / J Cancer 2018;9(1):41-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-01-01 / J Cancer 2018;9(1):41-532018-01-01 00:00:002018-01-01 00:00:00Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-06-03 / Arch. Virol. 2017 Sep;162(9):2705-2713
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-06-03 / Arch. Virol. 2017 Sep;162(9):2705-27132017-06-03 00:00:002019-02-15 08:39:31Evaluation of the oncolytic potential of RB Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-18 / Oncotarget 2017 Apr;8(16):27252-27262
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-18 / Oncotarget 2017 Apr;8(16):27252-272622017-04-18 00:00:002019-02-15 08:39:10Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-03-22 / Exp. Cell Res. 2017 05;354(2):112-121
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-03-22 / Exp. Cell Res. 2017 05;354(2):112-1212017-03-22 00:00:002019-02-15 08:39:30Temperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines
